HIV & aging

The advancement of exceptionally dynamic hostile to retroviral treatment (HAART) for HIV contamination in the 1990s is one of present day drug's most sensational examples of overcoming adversity. Once successfully a capital punishment, HIV disease can now be viewed as a genuine, yet to a great extent sensible, interminable condition. Today, a man who starts HAART can sensibly hope to experience another 30 to 50 years and regularly well into more seasoned age. In any case, large portions of the medications used to treat HIV have not been around for long. While transient reactions are very much inquired about and reported, longer-term symptoms are less surely knew. Some HIV drugs influence the kidneys, liver, bones and heart in unpretentious ways. As a major aspect of your normal wellbeing checking, your medicinal services proficient will watch out for how well your body is functioning, so any issues can be distinguished and treated early.

  • Systems biology in HIV, METH and cART
  • HIV- diagnosis, retroviral transmission and prevention
  • Mother-to-child transmission of HIV
  • Social, cultural, economic and political issues of sexuality
  • Opportunistic diseases in HIV

Related Conference of HIV & aging

September 01-02, 2017

4th International Conference on Parasitology

Prague, Czech Republic
November 2-3, 2017

9th World Congress and Expo on Immunology

Atlanta, Georgia, USA
November 02-03, 2017

9th World Congress on Immunity, Inflammation and Immunotherapies

Atlanta, Georgia, USA
November 06-07, 2017

2nd International Conference on Autoimmunity

Frankfurt, Germany
November 08-09, 2017

3rd Antibodies and Bio Therapeutics Congress & B2B

Las Vegas, Nevada, USA
November 13-14, 2017

5th International Conference on HIV/AIDS, STDs and STIs

Las Vegas, Nevada, USA
Dec 14-15, 2017

World Immunology Congress

Dubai, UAE

9th European Immunology Conference

June 14-16, 2018 Rome, Italy

HIV & aging Conference Speakers

Recommended Sessions

Related Journals

Are you interested in